home.social

#24weeks — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #24weeks, aggregated by home.social.

  1. DATE: May 16, 2026 at 10:00AM
    SOURCE: PSYCHIATRIC TIMES

    Direct article link at end of text block below.

    XPro1595 showed directionally consistent benefit across cognitive, global, functional, behavioral, and biomarker endpoints over 24 weeks in an Alzheimer disease with inflammation subgroup, with no amyloid-related imaging abnormalities. t.co/nJ6kkWsJWG

    Here are any URLs found in the article text:

    t.co/nJ6kkWsJWG

    Articles can be found by scrolling down the page at Articles can be found at psychiatrictimes.com/news".

    -------------------------------------------------

    DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #psychotherapist #Alzheimer'sResearch #CognitiveBenefit #Biomarkers #InflammationSubtype #24Weeks results

  2. DATE: May 16, 2026 at 10:00AM
    SOURCE: PSYCHIATRIC TIMES

    Direct article link at end of text block below.

    XPro1595 showed directionally consistent benefit across cognitive, global, functional, behavioral, and biomarker endpoints over 24 weeks in an Alzheimer disease with inflammation subgroup, with no amyloid-related imaging abnormalities. t.co/nJ6kkWsJWG

    Here are any URLs found in the article text:

    t.co/nJ6kkWsJWG

    Articles can be found by scrolling down the page at Articles can be found at psychiatrictimes.com/news".

    -------------------------------------------------

    DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #psychotherapist #Alzheimer'sResearch #CognitiveBenefit #Biomarkers #InflammationSubtype #24Weeks results

  3. DATE: May 16, 2026 at 10:00AM
    SOURCE: PSYCHIATRIC TIMES

    Direct article link at end of text block below.

    XPro1595 showed directionally consistent benefit across cognitive, global, functional, behavioral, and biomarker endpoints over 24 weeks in an Alzheimer disease with inflammation subgroup, with no amyloid-related imaging abnormalities. t.co/nJ6kkWsJWG

    Here are any URLs found in the article text:

    t.co/nJ6kkWsJWG

    Articles can be found by scrolling down the page at Articles can be found at psychiatrictimes.com/news".

    -------------------------------------------------

    DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #psychotherapist #Alzheimer'sResearch #CognitiveBenefit #Biomarkers #InflammationSubtype #24Weeks results